NovoCure Ltd

NVCR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001194459-26-000001
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: DOYLE WILLIAM F (Chair)

Summary

Type

Sell

Net shares

+328,397

% of shares

100.00%

Amount (USD)

$932,883

Insider confidence score

97.5 out of 100

Positive

  • Massive buy (≥10% of shares)
  • Large buy amount ($250K+)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Grant

Date

2026-03-03

Code

A

Net shares

+200,000.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

200,000.0

Transaction 2

Security

Ordinary Shares

Action

Grant

Date

2026-03-03

Code

A

Net shares

+200,284.0

Acquired/Disposed

Acquired

Shares Owned Before

200,000.0

Shares Owned After

400,284.0

Transaction 3

Security

Ordinary Shares

Action

Sell

Date

2026-03-03

Code

S

Net shares

-50,557.0

Price per Share

$12.79

Amount (USD)

$646,447.08

Acquired/Disposed

Disposed

Shares Owned Before

400,284.0

Shares Owned After

349,727.0

Transaction 4

Security

Ordinary Shares

Action

Sell

Date

2026-03-03

Code

S

Net shares

-21,330.0

Price per Share

$13.43

Amount (USD)

$286,436.30

Acquired/Disposed

Disposed

Shares Owned Before

349,727.0

Shares Owned After

328,397.0

Derivative Transactions

Transaction 1

Security

Stock Option (Right to Buy)

Action

Grant

Date

2026-03-03

Code

A

Net shares

+258,445.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

258,445.0

Transaction 2

Security

Stock Option (Right to Buy)

Action

Grant

Date

2026-03-03

Code

A

Net shares

+30,072.0

Acquired/Disposed

Acquired

Shares Owned Before

258,445.0

Shares Owned After

288,517.0

Filing's footnotes

1. Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.

2. Represents vesting of performance-based restricted stock units.

3. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Performance-Based Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

4. This transaction was executed in multiple trades at prices ranging from $12.299 USD to $13.277 USD; the price reported above reflects the weighted average sale price.

5. This transaction was executed in multiple trades at prices ranging from $13.35 USD to $13.52 USD; the price reported above reflects the weighted average sale price.

6. Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.